Aperio Group’s Intellia Therapeutics NTLA Stock Holding History

Aperio Group’s Portfolio NTLA Stock Details NTLA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$1.15M	Buy
2020 Q3	$390K	Sell
2020 Q2	$428K	Sell
2020 Q1	$321K	Buy
2019 Q4	$168K	Buy
2019 Q3	–	Sell
2019 Q2	$83K	Buy